金寶通(00320.HK)授出930萬股獎勵股份
格隆匯3月20日丨金寶通(00320.HK)發佈公吿,2025年3月20日,公司根據2023年股份獎勵計劃向集團僱員(“承授人”)授出合共930萬份獎勵,惟須待承授人接納後方可作實。各獎勵均指在授出該等獎勵的若干條款及條件的規限下,收取一股獎勵股份的有條件權利。
授予承授人的930萬股獎勵股份佔於本公吿日期公司已發行股本約1.1%。經計及於授出日期的收市價每股股份0.41港元,930萬股獎勵股份的價值約為381.3萬港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.